Oppenheimer Asset Management Inc. Makes New $4.53 Million Investment in Cabot Corporation $CBT

Key Points

• Oppenheimer Asset Management purchased 49,852 Cabot shares worth approximately $4.53 million, while institutional investors collectively own 93.18% of the company.
• Cabot reported quarterly revenue of $982 million and adjusted earnings of $1.67 per share, narrowly beating analyst estimates; revenue increased 6.4% year over year. The company maintained fiscal 2026 EPS guidance of $6.15–$6.45.
• Cabot declared a quarterly dividend of $0.4725 per share, equivalent to an annualized $1.89 payout and a 2.2% yield. Analysts’ consensus rating remains “Hold”, with an average price target of $89.

Oppenheimer Asset Management Inc. purchased a new stake in Cabot Corporation (NYSE:CBT - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 49,852 shares of the specialty chemicals company's stock, valued at approximately $4,528,000. Oppenheimer Asset Management Inc. owned 0.10% of Cabot at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in CBT. Fuller & Thaler Asset Management Inc. boosted its stake in Cabot by 5.6% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company's stock valued at $155,315,000 after buying an additional 124,613 shares during the period. State Street Corp raised its holdings in shares of Cabot by 1.0% in the 4th quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company's stock valued at $134,256,000 after acquiring an additional 20,021 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Cabot by 4.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company's stock valued at $131,253,000 after acquiring an additional 79,499 shares during the last quarter. Bank of America Corp DE boosted its position in shares of Cabot by 3.9% during the 3rd quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company's stock valued at $128,032,000 after acquiring an additional 63,080 shares during the last quarter. Finally, Sei Investments Co. grew its holdings in shares of Cabot by 6.5% during the first quarter. Sei Investments Co. now owns 1,051,578 shares of the specialty chemicals company's stock worth $79,194,000 after purchasing an additional 64,122 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cabot

In other news, CEO Sean D. Keohane sold 91,923 shares of Cabot stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares in the company, valued at approximately $34,921,218.94. This trade represents a 18.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 3.08% of the company's stock.

Cabot Stock Performance

Shares of Cabot stock opened at $87.82 on Friday. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $94.53. The firm has a market capitalization of $4.53 billion, a P/E ratio of 24.74, a P/E/G ratio of 11.47 and a beta of 0.84. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. The business has a fifty day simple moving average of $88.12 and a two-hundred day simple moving average of $80.40.

Cabot (NYSE:CBT - Get Free Report) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping analysts' consensus estimates of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. During the same period in the prior year, the firm earned $1.90 EPS. The company's revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, equities analysts forecast that Cabot Corporation will post 6.33 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. Cabot's dividend payout ratio (DPR) is currently 53.24%.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Truist Financial set a $100.00 price objective on shares of Cabot in a research report on Wednesday, August 5th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cabot in a research note on Tuesday, May 26th. JPMorgan Chase & Co. raised their target price on shares of Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a report on Friday, August 7th. Wall Street Zen raised Cabot from a "hold" rating to a "buy" rating in a research note on Sunday, August 9th. Finally, Mizuho lifted their price objective on Cabot from $80.00 to $90.00 and gave the stock a "neutral" rating in a research report on Thursday, June 25th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Cabot presently has an average rating of "Hold" and a consensus price target of $89.00.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source